TET2 and B-cell non-Hodgkin lymphoma: One notable exception is the high incidence of TET2 somatic mutations in T‐cell lymphomas vs B‐cell lymphomas in germline mutation carriers, which may reflect differences in survival observed in Tet2 KO mouse models.134